Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12624000822583
Ethics application status
Approved
Date submitted
24/05/2024
Date registered
4/07/2024
Date last updated
4/07/2024
Date data sharing statement initially provided
4/07/2024
Type of registration
Prospectively registered
Titles & IDs
Public title
Stomach Electrical Activity Following Oesophageal Cancer Surgery
Query!
Scientific title
Measuring Gastric Conduit Electrophysiology at 12 months post Ivor-Lewis Oesophagectomy to Characterise Delayed Gastric Conduit Emptying after Oesophageal Cancer Surgery
Query!
Secondary ID [1]
312214
0
None
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Delayed gastric conduit emptying
333892
0
Query!
Oesophageal cancer
333971
0
Query!
Condition category
Condition code
Oral and Gastrointestinal
330571
330571
0
0
Query!
Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Query!
Cancer
330639
330639
0
0
Query!
Oesophageal (gullet)
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Gastric Alimetry is a non-invasive transcutaneous device which has been validated in assessing gastric motility in patients, using cutaneous sensors to monitor gastric electrophysiology and comparing to patient reported symptoms using patient feedback tools. The technology uses a high-resolution array of 64 electrodes applied to the anterior abdominal wall and epigastrium with the intention of measuring gastric electrical activity. It is comparable to an ECG test of the heart, however longer in duration to account for the lower frequency of the gastric electrical activity. Its non-invasive component provides an acceptable alternative to other measurement tools for gastric electrical activity, however the clinical utility in patients post-oesophagectomy is not yet explored.
Patients will only be assessed with Gastric Alimetry as part of their enrollment in the study.
Information that will be assessed from participants includes information from electronic medical records, study-specific questionnaires, as well as gastric motility activity. The patient questionnaire is anticipated to take 20 minutes to complete, and the gastric motility assessment is anticipated to take approximately 4 hours.
The administration of the gastric motility assessment will be undertaken by a trained medical doctor.
Adherence to the gastric motility assessment is binary and measured by whether the participant is able to complete the entire duration of the assessment as well as all study questionnaires.
Query!
Intervention code [1]
328711
0
Diagnosis / Prognosis
Query!
Comparator / control treatment
Participants with no clinical or radiological evidence of delayed gastric conduit emptying will undergo the same assessment as the intervention/exposure group, that being Gastric Alimetry motility assessment as well as symptom questionnaires.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
338325
0
Gastric motility activity - Electrical mapping composite outcome
- Principal gastric frequency
- BMI-adjusted average amplitude
Query!
Assessment method [1]
338325
0
Alimetry electrogastrogram - Body surface gastric mapping
Query!
Timepoint [1]
338325
0
Continuous Gastric Alimetry data collection will occur during a the four-hour assessment period.
Query!
Secondary outcome [1]
436846
0
Nil
Query!
Assessment method [1]
436846
0
Nil
Query!
Timepoint [1]
436846
0
Nil
Query!
Eligibility
Key inclusion criteria
- Patients least 12 months post oesophagectomy at Peter MacCallum Cancer Centre
- Adults aged 18 and over
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
None
Query!
Study design
Purpose of the study
Diagnosis
Query!
Allocation to intervention
Non-randomised trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Statistical testing will be performed according to the data type. To compare results between symptomatic patients and controls, we will employ relevant tests to the parameters / variables such as the two-sided Fisher’s exact test for the categorical variables and one-way analysis of variance (ANOVA) for continuous variables. Correlation testing will be used to correlate clinical symptoms vs electrophysiological outcomes in the patient groups.
To do this, the sub-type of electrical abnormalities will be determined, based on a previous article describes that describes the various amplitude subtype patterns – low rhythm stability/low amplitude, high stable amplitude, isolated frequency deviations – and their physiological meaning. A total symptom burden bar, constructed from patient-reported outcomes, will be compared against transient spectral abnormalities from the gastric amplitude curves. This comparison will be made through a subjective visual assessment whereby the timing, type and number of symptom ‘events’ are correlated against gastric electrical activity changes. Additionally, we will also determine the associations between all the study variables with Pearson’s correlation coefficient and will report statistically significant correlations after Benjamini-Hochberg correction (a=.05).
Slow wave parameters will also be compared to quality of life and symptom scores (PAGI-SYM, PAGI-QoL)
Query!
Recruitment
Recruitment status
Not yet recruiting
Query!
Date of first participant enrolment
Anticipated
31/07/2024
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
30/07/2026
Query!
Actual
Query!
Date of last data collection
Anticipated
30/07/2026
Query!
Actual
Query!
Sample size
Target
40
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
VIC
Query!
Recruitment hospital [1]
26572
0
Peter MacCallum Cancer Centre - Melbourne
Query!
Recruitment postcode(s) [1]
42615
0
3052 - Melbourne University
Query!
Recruitment postcode(s) [2]
42616
0
3000 - Melbourne
Query!
Funding & Sponsors
Funding source category [1]
316597
0
Self funded/Unfunded
Query!
Name [1]
316597
0
Unfunded
Query!
Address [1]
316597
0
Query!
Country [1]
316597
0
Query!
Primary sponsor type
Individual
Query!
Name
A/Prof Cuong Duong
Query!
Address
Query!
Country
Australia
Query!
Secondary sponsor category [1]
318778
0
Hospital
Query!
Name [1]
318778
0
Clinical Research Development and Operations (CRDO) of Peter MacCallum Cancer Centre
Query!
Address [1]
318778
0
Query!
Country [1]
318778
0
Australia
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
315375
0
Peter MacCallum Cancer Centre Human Research Ethics Committee
Query!
Ethics committee address [1]
315375
0
https://www.petermac.org/research/doing-research-us/ethics-governance
Query!
Ethics committee country [1]
315375
0
Australia
Query!
Date submitted for ethics approval [1]
315375
0
29/02/2024
Query!
Approval date [1]
315375
0
23/04/2024
Query!
Ethics approval number [1]
315375
0
HREC/104754/PMCC
Query!
Summary
Brief summary
This study investigates the characteristic electrical activity of the stomach conduit in patients with delayed gastric conduit emptying (DGCE), a clinical condition characterised by persistent nausea and difficulty swallowing after oesophageal cancer surgery. Who is it for? You may be eligible for this study if you are an adult male or female who has previous has had oesophageal cancer surgery at Peter MacCallum Cancer Centre atleast 12 months ago. Study details All participants will undergo a series of patient questionnaires regarding their symptoms, followed by a 4-hour gastric motility assessment using the device known as 'Gastric Alimetry', which works similarly to an ECG for the stomach. This will facilitate the identification of electrical activity characteristics for DGCE and validate the role of Alimetry in diagnosing DGCE.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
134506
0
A/Prof Cuong Duong
Query!
Address
134506
0
Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne VIC 3052
Query!
Country
134506
0
Australia
Query!
Phone
134506
0
+61 3 8559 7665
Query!
Fax
134506
0
Query!
Email
134506
0
[email protected]
Query!
Contact person for public queries
Name
134507
0
Jonathan Sivakumar
Query!
Address
134507
0
Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne VIC 3052
Query!
Country
134507
0
Australia
Query!
Phone
134507
0
+61 3 8559 5000
Query!
Fax
134507
0
Query!
Email
134507
0
[email protected]
Query!
Contact person for scientific queries
Name
134508
0
Jonathan Sivakumar
Query!
Address
134508
0
Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne VIC 3052
Query!
Country
134508
0
Australia
Query!
Phone
134508
0
+61 3 8559 5000
Query!
Fax
134508
0
Query!
Email
134508
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
Individual participant data will not be available as this is a de-identified clinical study and the principal of confidentially will be upheld to protect patient privacy.
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF